Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Novartis
Novartis
M.D. Anderson Cancer Center
Medical College of Wisconsin
Mayo Clinic
University of Virginia
Bayer
Children's National Research Institute
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
SWOG Cancer Research Network
Gustave Roussy, Cancer Campus, Grand Paris